Exposure to particulate hexavalent chromium exacerbates allergic asthma pathology

Toxicology and Applied Pharmacology

Volumn 259, Issue 1, 2012, Pages 38-44

  Schneider, Brent C ^a   Constant, Stephanie L ^a,c   Patierno, Steven R ^a,b   Jurjus, Rosalyn A ^b   Ceryak, Susan M ^a  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b GEORGE WASHINGTON UNIVERSITY   (United States)

^c NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

Asthma; Hexavalent chromium; Inflammation; Lung

Indexed keywords

CHROMIC ACID; OVALBUMIN; UNCLASSIFIED DRUG; ZINC CHROMATE;

ALLERGIC ASTHMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; EOSINOPHIL; FEMALE; HISTOPATHOLOGY; INFLAMMATION; MOUSE; NEUTROPHIL; NONHUMAN; PARTICULATE MATTER; PHENOTYPE;

ANIMALS; ASTHMA; BRONCHOALVEOLAR LAVAGE FLUID; CHROMIUM; DISEASE MODELS, ANIMAL; FEMALE; INHALATION EXPOSURE; INTERLEUKIN-13; LUNG; MICE; MICE, INBRED BALB C; NEUTROPHIL INFILTRATION; OVALBUMIN; PARTICULATE MATTER; RESPIRATORY MUCOSA; TH2 CELLS;

MUS;

EID: 84857113396     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2011.12.001     Document Type: Article

References (32)

1. Adams R.J., Wilson D.H., Taylor A.W., Daly A., Tursan d.E., Dal Grande E., Ruffin R.E. Coexistent chronic conditions and asthma quality of life: a population-based study. Chest 2006, 129:285-291.
2. Balsley M.A., Malesevic M., Stemmy E.J., Gigley J., Jurjus R.A., Herzog D., Bukrinsky M.I., Fischer G., Constant S.L. A cell-impermeable cyclosporine A derivative reduces pathology in a mouse model of allergic lung inflammation. J. Immunol. 2010, 185:7663-7670.
3. Beaver L.M., Stemmy E.J., Constant S.L., Schwartz A., Little L.G., Gigley J.P., Chun G., Sugden K.D., Ceryak S.M., Patierno S.R. Lung injury, inflammation and Akt signaling following inhalation of particulate hexavalent chromium. Toxicol. Appl. Pharmacol. 2009, 235:47-56.
4. Beaver L.M., Stemmy E.J., Schwartz A.M., Damsker J.M., Constant S.L., Ceryak S.M., Patierno S.R. Lung inflammation, injury, and proliferative response after repetitive particulate hexavalent chromium exposure. Environ. Health Perspect. 2009, 117:1896-1902.
5. Borish L., Culp J.A. Asthma: a syndrome composed of heterogeneous diseases. Ann. Allergy Asthma Immunol. 2008, 101:1-8.
6. Bright P., Burge P.S., O'Hickey S.P., Gannon P.F., Robertson A.S., Boran A. Occupational asthma due to chrome and nickel electroplating. Thorax 1997, 52:28-32.
7. Brooks S.M., Hammad Y., Richards I., Giovinco-Barbas J., Jenkins K. The spectrum of irritant-induced asthma: sudden and not-so-sudden onset and the role of allergy. Chest 1998, 113:42-49.
8. Cohn L., Elias J.A., Chupp G.L. Asthma: mechanisms of disease persistence and progression. Annu. Rev. Immunol. 2004, 22(789-815):789-815.
9. Cookson W. The alliance of genes and environment in asthma and allergy. Nature 1999, 402:B5-B11.
10. Douwes J., Gibson P., Pekkanen J., Pearce N. Non-eosinophilic asthma: importance and possible mechanisms. Thorax 2002, 57:643-648.
11. Fahy J.V. Goblet cell and mucin gene abnormalities in asthma. Chest 2002, 122:320S-326S.
12. Fernandez-Nieto M., Quirce S., Carnes J., Sastre J. Occupational asthma due to chromium and nickel salts. Int. Arch. Occup. Environ. Health 2006, 79:483-486.
13. Gibbs B.F., Haas H., Falcone F.H., Albrecht C., Vollrath I.B., Noll T., Wolff H.H., Amon U. Purified human peripheral blood basophils release interleukin-13 and preformed interleukin-4 following immunological activation. Eur. J. Immunol. 1996, 26:2493-2498.
14. Gibson P.G., Simpson J.L., Saltos N. Heterogeneity of airway inflammation in persistent asthma: evidence of neutrophilic inflammation and increased sputum interleukin-8. Chest 2001, 119:1329-1336.
15. Gwinn W.M., Damsker J.M., Falahati R., Okwumabua I., Kelly-Welch A., Keegan A.D., Vanpouille C., Lee J.J., Dent L.A., Leitenberg D., Bukrinsky M.I., Constant S.L. Novel approach to inhibit asthma-mediated lung inflammation using anti-CD147 intervention. J. Immunol. 2006, 177:4870-4879.
16. Hannu T., Piipari R., Kasurinen H., Keskinen H., Tuppurainen M., Tuomi T. Occupational asthma due to manual metal-arc welding of special stainless steels. Eur. Respir. J. 2005, 26:736-739.
17. Ishikawa Y., Nakagawa K., Satoh Y., Kitagawa T., Sugano H., Hirano T., Tsuchiya E. "Hot spots" of chromium accumulation at bifurcations of chromate workers' bronchi. Cancer Res. 1994, 54:2342-2346.
18. Joules H. Asthma from sensitisation to chromium. Lancet 1932, 220:182-183.
19. Kasaian M.T., Miller D.K. IL-13 as a therapeutic target for respiratory disease. Biochem. Pharmacol. 2008, 76:147-155.
20. Kobayashi H., Okayama Y., Ishizuka T., Pawankar R., Ra C., Mori M. Production of IL-13 by human lung mast cells in response to Fcepsilon receptor cross-linkage. Clin. Exp. Allergy 1998, 28:1219-1227.
21. Lauwerys B.R., Garot N., Renauld J.C., Houssiau F.A. Cytokine production and killer activity of NK/T-NK cells derived with IL-2, IL-15, or the combination of IL-12 and IL-18. J. Immunol. 2000, 165:1847-1853.
22. Leikauf G.D. Hazardous air pollutants and asthma. Environ. Health Perspect. 2002, 110(Suppl 4):505-526.
23. Leroyer C., Dewitte J.D., Bassanets A., Boutoux M., Daniel C., Clavier J. Occupational asthma due to chromium. Respiration 1998, 65:403-405.
24. Moller D.R., Brooks S.M., Bernstein D.I., Cassedy K., Enrione M., Bernstein I.L. Delayed anaphylactoid reaction in a worker exposed to chromium. J. Allergy Clin. Immunol. 1986, 77:451-456.
25. Novey H.S., Habib M., Wells I.D. Asthma and IgE antibodies induced by chromium and nickel salts. J. Allergy Clin. Immunol. 1983, 72:407-412.
26. Olaguibel J.M., Basomba A. Occupational asthma induced by chromium salts. Allergol. Immunopathol. (Madr.) 1989, 17:133-136.
27. Park H.S., Yu H.J., Jung K.S. Occupational asthma caused by chromium. Clin. Exp. Allergy 1994, 24:676-681.
28. Pecaric-Petkovic T., Didichenko S.A., Kaempfer S., Spiegl N., Dahinden C.A. Human basophils and eosinophils are the direct target leukocytes of the novel IL-1 family member IL-33. Blood 2009, 113:1526-1534.
29. Smith A.R. Chrome poisoning with manifestations of sensitization. J. Am. Med. Assoc. 1931, 97:95-98.
30. Stock P., Akbari O. Recent advances in the role of NKT cells in allergic diseases and asthma. Curr. Allergy Asthma Rep. 2008, 8:165-170.
31. U.S.Environmental Protection Agency Toxicological Review of Hexavalent Chromium Ref Type: Generic. http://www.epa.gov/ncea/iris/toxreviews/0144tr.pdfU.
32. Wills-Karp M. Interleukin-13 in asthma pathogenesis. Immunol. Rev. 2004, 202:175-190.